more insilco news10 Mar 2021 17:17
insilco has now had its Chemistry 42 AI system incorporated into UCB's drug discovery system.im not posting a link, as it won't benefit Regent.it does, however, make me wonder even more how long Zhavoronkov will remain associated with DLI. reluctantly I'm moving more to your view bignose, that to satisfy the HK regulators mellon looked around for something he could move into regent that was not core to insilco's future (obviously DLI isn't or they would have kept it). i hope this is wrong, but i fear we may end up with a non performing asset (draining finances) in isolation.i do hope I'm wrong.